Table 4 Comparing T1, T2 and extracellular volume in patients with cardiac symptoms before and after COVID-19 vaccination
Before 1st Vaccine Dose | After 2nd Vaccine Dose | p-value | |
|---|---|---|---|
Patients with chest pain (n = 15) | |||
Global Native T1 Myocardium (msec) | 1080 (1005–1101) | 1039 (1007–1081) | 0.520 |
Global Native T2 Myocardium (msec) | 48.5 (44.5–51.2) | 48.8 (46.5–52.1) | 0.756 |
ECV Myocardium (%) | 28.4 (26.4–32.3) | 27.0 (24.6–31.1) | 0.254 |
Patients with palpitations (n = 7) | |||
Global Native T1 Myocardium (msec) | 1086 (1044–1099) | 1088 (1039–1139) | 0.749 |
Global Native T2 Myocardium (msec) | 53.1 (46.2–57.6) | 46.7 (45.9–53.2) | 0.338 |
ECV myocardium (%) | 28.3 (26.4–31.9) | 27.0 (24.6–32.5) | 0.565 |
Patients with SOB (n = 11) | |||
Global Native T1 Myocardium (msec) | 1022 (979–1090) | 1049 (998–1081) | 0.533 |
Global Native T2 Myocardium (msec) | 49.3 (46.6–53.1) | 48.2 (46.5–52.7) | 0.670 |
ECV Myocardium (%) | 26.3 (22.3–28.6) | 24.6 (22.6–28.7) | 0.922 |